Funded Tech Companies
Proteon Therapeutics
Proteon Therapeutics is a leading biopharmaceutical company, based in Waltham. Financial backing was provided by Pharmstandard, Deerfield Capital and Vectis Healthcare and Life Sciences Fund.
Company Overview
Company Name
Proteon Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
200 West St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Company Background Information
Overview
Proteon Therapeutics (NASDAQ: PRTO) is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/22/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Noyes
Chief Financial Officer
George Eldridge
Chief Medical Officer
Steven Burke
VP - Bus. Development
Daniel Gottlieb
VP - General Counsel
Matthew Kowalsky
VP - Manufacturing
John Najim
VP - Marketing
Scott Toner
VP - R & D
Pamela Gustafson
Company Investors
- Pharmstandard
- Deerfield Capital
- Vectis Healthcare and Life Sciences Fund
- Skyline Ventures (John Freund)
- Bessemer Venture Partners (Felda Hardymon)
- Prism VentureWorks (Brendan O'Leary)
- Abingworth (Timothy Haines)
- Intersouth Partners (James Rosen)
- Devon Park Bioventures
- MPM Capital (Todd Foley)
- TVM Capital (Hubert Birner)
- MPM Capital (Steven Peter)
- Skyline Ventures (David Lowe)
- Intersouth Partners (Garheng Kong)
- TVM Capital (Stephen Hoffman)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs